• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • R&D programs and partnerships
      • BioPharMEMS
      • MIMLIVEROnChip
      • Nanostem
      • NEUROCELL3D
      • ONCO3D
      • RHU CHOPIN
      • ScaLABle-MEAT
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Customer testimonials
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Careers
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
  • Support
    • BIOMIMESYS® Custom
    • Dermocosmetology
      • Anti-Aging
      • Skin Microbiota
      • Anti-oxidant
        • Oxidative stress
        • Lipid peroxidation
        • Glutathione Stock
      • Wound Healing
      • Cosmetics custom developments
    • Pharmacology
      • Parkinson
      • Alzheimer
      • Migration
      • Cell cycle arrest
  • Ressources
    • Publications
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificate of Analyse
    • Protocols
    • Frequently Asked Questions
  • Contacts
    • How to contact us ?
    • Subscribe to our Newsletter

stage

Join Us

Nous recherchons un ou une stagiaire R&D pour le développement de tests d’efficacité in vitro en dermocosmétologie

Durée : 3 mois minimum Lieu : HCS Pharma, Parc Eurasanté, Loos (59) Missions : Au sein de la société HCS Pharma, vous intégrerez le laboratoire en charge des études en dermocosmétologie qui a pour mission de développer de nouveaux tests in vitro et d’étudier l’efficacité cosmétique de principes actifs. Read more…

By Grégory MAUBON, 1 month1 month ago
Clic to get more information

BIOMIMESYS®

Contacts
Contact us with this form!
Or
+33 769 999 137

Newsletter

Recent Posts
  • How to create physiologically-relevant 3D in vitro models using BIOMIMESYS® hydroscaffold
  • The skin microbiota, a fundamental part of in vitro studies
  • Agrément CIR jusqu’en 2023 pour HCS Pharma
  • Oxidative stress : definition and biological effects
  • On the importance of extracellular matrix of the skin for efficient 3D cell culture models
We talk about …
3D 3D cell culture 3D culture BIOMIMESYS BIOMIMESYS Brain blood brain barrier brain cancer cell CHOPIN congress cosmetology dermocosmetology drug ECM ELRIG event extracellular matrix forum labo genotoxicity HCA HCS hcs pharma High content screening hyaluronic acid imaging innovation in vitro liver meeting Microbiota microenvironment microscopy model Molecular Devices NEUROCELL3D neurotoxicity oncology Parkinson phenotypic screening picture rennes screening skin toxicology
  • Company
  • BIOMIMESYS®
  • Support
  • Ressources
  • Contacts
HCS Pharma (c) 2020 | Hestia | Powered by WordPress